Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-127-1
CAS number: 103-60-6
Table 1: Skin Reaction Summary
* Atonia and eschar were also observed for the high dosage group. During
the dosage period, atonia had an index of 1.0 and occurred for 1/10
rats; during the post dosage period, atonia had an index of 10.0 and
occurred for 1/10 rats. During the dosage period, eschar had an index of
11.0 and occurred for 3/10 rats; during the postdosage period, eschar
had an index of 4.0 and occurred for 2/10 rats. Exfoliation and edema
were not observed for rats in any of the dosage groups.
Table 2: Litter Data Summary
* Significantly different from the vehicle control at P ≤0.05.
**Significant different from the vehicle control at P ≤ 0.01.
[N] number of values averaged.
Table 3: Fetal Alterations Summary
Table 4: Gross External Fetal-Alterations Summary
Table 5: Soft Tissue Fetal Alterations Summary
** No soft tissue fetal alterations were found in this study
Table 6: Skeletal Fetal Alterations Summary
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
Do not show this message again